This process facilitates the removal of dysfunctional mitochondria, a major source of reactive oxygen species (ROS); therefore, LACTB2 provides a survival advantage to irradiated NPC cells. This evidence concerns the gene LACTB2 and nasopharyngeal carcinoma.